Global Dermatology OTC Medications Market Insights and Forecast to 2027

1 Study Coverage

• 1.1 Dermatology OTC Medications Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Dermatology OTC Medications Market Size Growth Rate by Type
  • 1.4.2 External Use
  • 1.4.3 Oral
• 1.3 Market by Application
  • 1.3.1 Global Dermatology OTC Medications Market Size Growth Rate by Application
  • 1.3.2 Hospital
  • 1.3.3 Drug Store
  • 1.3.4 Other
• 1.4 Study Objectives
• 1.5 Years Considered

2 Executive Summary

• 2.1 Global Dermatology OTC Medications Sales Estimates and Forecasts 2016-2027
• 2.2 Global Dermatology OTC Medications Revenue Estimates and Forecasts 2016-2027
• 2.3 Global Dermatology OTC Medications Revenue by Region: 2016 VS 2021 VS 2027
• 2.4 Global Top Dermatology OTC Medications Regions by Sales
  • 2.4.1 Global Top Dermatology OTC Medications Regions by Sales (2016-2021)
  • 2.4.2 Global Top Dermatology OTC Medications Regions by Sales (2022-2027)
• 2.5 Global Top Dermatology OTC Medications Regions by Revenue
  • 2.5.1 Global Top Dermatology OTC Medications Regions by Revenue (2016-2021)
  • 2.5.2 Global Top Dermatology OTC Medications Regions by Revenue (2022-2027)
• 2.6 North America
• 2.7 Europe
• 2.8 Asia-Pacific
• 2.9 Latin America
• 2.10 Middle East & Africa

3 Competition by Manufacturers

• 3.1 Global Dermatology OTC Medications Sales by Manufacturers
  • 3.1.1 Global Top Dermatology OTC Medications Manufacturers by Sales (2016-2021)
  • 3.1.2 Global Top Dermatology OTC Medications Manufacturers Market Share by Sales (2016-2021)
  • 3.1.3 Global Top 10 and Top 5 Companies by Dermatology OTC Medications Sales in 2020
• 3.2 Global Dermatology OTC Medications Revenue by Manufacturers
  • 3.2.1 Global Top Dermatology OTC Medications Manufacturers by Revenue (2016-2021)
  • 3.2.2 Global Top Dermatology OTC Medications Manufacturers Market Share by Revenue (2016-2021)
  • 3.2.3 Global Top 10 and Top 5 Companies by Dermatology OTC Medications Revenue in 2020
• 3.3 Global Dermatology OTC Medications Sales Price by Manufacturers
• 3.4 Analysis of Competitive Landscape
  • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Dermatology OTC Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.4.3 Global Dermatology OTC Medications Manufacturers Geographical Distribution
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Global Dermatology OTC Medications Sales by Type
  • 4.1.1 Global Dermatology OTC Medications Historical Sales by Type (2016-2021)
  • 4.1.2 Global Dermatology OTC Medications Forecasted Sales by Type (2022-2027)
  • 4.1.3 Global Dermatology OTC Medications Sales Market Share by Type (2016-2027)
• 4.2 Global Dermatology OTC Medications Revenue by Type
  • 4.2.1 Global Dermatology OTC Medications Historical Revenue by Type (2016-2021)
  • 4.2.2 Global Dermatology OTC Medications Forecasted Revenue by Type (2022-2027)
  • 4.2.3 Global Dermatology OTC Medications Revenue Market Share by Type (2016-2027)
• 4.3 Global Dermatology OTC Medications Price by Type
  • 4.3.1 Global Dermatology OTC Medications Price by Type (2016-2021)
  • 4.3.2 Global Dermatology OTC Medications Price Forecast by Type (2022-2027)

5 Market Size by Application

• 5.1 Global Dermatology OTC Medications Sales by Application
  • 5.1.1 Global Dermatology OTC Medications Historical Sales by Application (2016-2021)
  • 5.1.2 Global Dermatology OTC Medications Forecasted Sales by Application (2022-2027)
  • 5.1.3 Global Dermatology OTC Medications Sales Market Share by Application (2016-2027)
• 5.2 Global Dermatology OTC Medications Revenue by Application
  • 5.2.1 Global Dermatology OTC Medications Historical Revenue by Application (2016-2021)
  • 5.2.2 Global Dermatology OTC Medications Forecasted Revenue by Application (2022-2027)
  • 5.2.3 Global Dermatology OTC Medications Revenue Market Share by Application (2016-2027)
• 5.3 Global Dermatology OTC Medications Price by Application
  • 5.3.1 Global Dermatology OTC Medications Price by Application (2016-2021)
  • 5.3.2 Global Dermatology OTC Medications Price Forecast by Application (2022-2027)

6 North America

• 6.1 North America Dermatology OTC Medications Market Size by Type
  • 6.1.1 North America Dermatology OTC Medications Sales by Type (2016-2027)
  • 6.1.2 North America Dermatology OTC Medications Revenue by Type (2016-2027)
• 6.2 North America Dermatology OTC Medications Market Size by Application
  • 6.2.1 North America Dermatology OTC Medications Sales by Application (2016-2027)
  • 6.2.2 North America Dermatology OTC Medications Revenue by Application (2016-2027)
• 6.3 North America Dermatology OTC Medications Market Size by Country
  • 6.3.1 North America Dermatology OTC Medications Sales by Country (2016-2027)
  • 6.3.2 North America Dermatology OTC Medications Revenue by Country (2016-2027)
  • 6.3.3 U.S.
  • 6.3.4 Canada

7 Europe

• 7.1 Europe Dermatology OTC Medications Market Size by Type
  • 7.1.1 Europe Dermatology OTC Medications Sales by Type (2017-2027)
  • 7.1.2 Europe Dermatology OTC Medications Revenue by Type (2017-2027)
• 7.2 Europe Dermatology OTC Medications Market Size by Application
  • 7.2.1 Europe Dermatology OTC Medications Sales by Application (2017-2027)
  • 7.2.2 Europe Dermatology OTC Medications Revenue by Application (2017-2027)
• 7.3 Europe Dermatology OTC Medications Market Size by Country
  • 7.3.1 Europe Dermatology OTC Medications Sales by Country (2017-2027)
  • 7.3.2 Europe Dermatology OTC Medications Revenue by Country (2017-2027)
  • 7.3.3 Germany
  • 7.3.4 France
  • 7.3.5 U.K.
  • 7.3.6 Italy
  • 7.3.7 Russia

8 Asia Pacific

• 8.1 Asia Pacific Dermatology OTC Medications Market Size by Type
  • 8.1.1 Asia Pacific Dermatology OTC Medications Sales by Type (2018-2027)
  • 8.1.2 Asia Pacific Dermatology OTC Medications Revenue by Type (2018-2027)
• 8.2 Asia Pacific Dermatology OTC Medications Market Size by Application
  • 8.2.1 Asia Pacific Dermatology OTC Medications Sales by Application (2018-2027)
  • 8.2.2 Asia Pacific Dermatology OTC Medications Revenue by Application (2018-2027)
• 8.3 Asia Pacific Dermatology OTC Medications Market Size by Region
  • 8.3.1 Asia Pacific Dermatology OTC Medications Sales by Region (2018-2027)
  • 8.3.2 Asia Pacific Dermatology OTC Medications Revenue by Region (2018-2027)
  • 8.3.3 China
  • 8.3.4 Japan
  • 8.3.5 South Korea
  • 8.3.6 India
  • 8.3.7 Australia
  • 8.3.8 Taiwan
  • 8.3.9 Indonesia
  • 8.3.10 Thailand
  • 8.3.11 Malaysia
  • 8.3.12 Philippines

9 Latin America

• 9.1 Latin America Dermatology OTC Medications Market Size by Type
  • 9.1.1 Latin America Dermatology OTC Medications Sales by Type (2019-2027)
  • 9.1.2 Latin America Dermatology OTC Medications Revenue by Type (2019-2027)
• 9.2 Latin America Dermatology OTC Medications Market Size by Application
  • 9.2.1 Latin America Dermatology OTC Medications Sales by Application (2019-2027)
  • 9.2.2 Latin America Dermatology OTC Medications Revenue by Application (2019-2027)
• 9.3 Latin America Dermatology OTC Medications Market Size by Country
  • 9.3.1 Latin America Dermatology OTC Medications Sales by Country (2019-2027)
  • 9.3.2 Latin America Dermatology OTC Medications Revenue by Country (2019-2027)
  • 9.3.3 Mexico
  • 9.3.4 Brazil
  • 9.3.5 Argentina

6 Middle East and Africa

• 6.1 Middle East and Africa Dermatology OTC Medications Market Size by Type
  • 6.1.1 Middle East and Africa Dermatology OTC Medications Sales by Type (2016-2027)
  • 6.1.2 Middle East and Africa Dermatology OTC Medications Revenue by Type (2016-2027)
• 6.2 Middle East and Africa Dermatology OTC Medications Market Size by Application
  • 6.2.1 Middle East and Africa Dermatology OTC Medications Sales by Application (2016-2027)
  • 6.2.2 Middle East and Africa Dermatology OTC Medications Revenue by Application (2016-2027)
• 6.3 Middle East and Africa Dermatology OTC Medications Market Size by Country
  • 6.3.1 Middle East and Africa Dermatology OTC Medications Sales by Country (2016-2027)
  • 6.3.2 Middle East and Africa Dermatology OTC Medications Revenue by Country (2016-2027)
  • 6.3.3 Turkey
  • 6.3.4 Saudi Arabia
  • 6.3.5 U.A.E

11 Company Profiles

• 11.1 Bayer
  • 11.1.1 Bayer Corporation Information
  • 11.1.2 Bayer Overview
  • 11.1.3 Bayer Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.1.4 Bayer Dermatology OTC Medications Product Description
  • 11.1.5 Bayer Related Developments
• 11.2 GSK
  • 11.2.1 GSK Corporation Information
  • 11.2.2 GSK Overview
  • 11.2.3 GSK Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.2.4 GSK Dermatology OTC Medications Product Description
  • 11.2.5 GSK Related Developments
• 11.3 Teva
  • 11.3.1 Teva Corporation Information
  • 11.3.2 Teva Overview
  • 11.3.3 Teva Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.3.4 Teva Dermatology OTC Medications Product Description
  • 11.3.5 Teva Related Developments
• 11.4 Johnson & Johnson
  • 11.4.1 Johnson & Johnson Corporation Information
  • 11.4.2 Johnson & Johnson Overview
  • 11.4.3 Johnson & Johnson Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.4.4 Johnson & Johnson Dermatology OTC Medications Product Description
  • 11.4.5 Johnson & Johnson Related Developments
• 11.5 Novartis
  • 11.5.1 Novartis Corporation Information
  • 11.5.2 Novartis Overview
  • 11.5.3 Novartis Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.5.4 Novartis Dermatology OTC Medications Product Description
  • 11.5.5 Novartis Related Developments
• 11.6 Mylan
  • 11.6.1 Mylan Corporation Information
  • 11.6.2 Mylan Overview
  • 11.6.3 Mylan Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.6.4 Mylan Dermatology OTC Medications Product Description
  • 11.6.5 Mylan Related Developments
• 11.7 Sun Pharmaceutical
  • 11.7.1 Sun Pharmaceutical Corporation Information
  • 11.7.2 Sun Pharmaceutical Overview
  • 11.7.3 Sun Pharmaceutical Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.7.4 Sun Pharmaceutical Dermatology OTC Medications Product Description
  • 11.7.5 Sun Pharmaceutical Related Developments
• 11.8 Aurobindo
  • 11.8.1 Aurobindo Corporation Information
  • 11.8.2 Aurobindo Overview
  • 11.8.3 Aurobindo Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.8.4 Aurobindo Dermatology OTC Medications Product Description
  • 11.8.5 Aurobindo Related Developments
• 11.9 Galderma
  • 11.9.1 Galderma Corporation Information
  • 11.9.2 Galderma Overview
  • 11.9.3 Galderma Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.9.4 Galderma Dermatology OTC Medications Product Description
  • 11.9.5 Galderma Related Developments
• 11.10 CR SANJIU
  • 11.10.1 CR SANJIU Corporation Information
  • 11.10.2 CR SANJIU Overview
  • 11.10.3 CR SANJIU Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.10.4 CR SANJIU Dermatology OTC Medications Product Description
  • 11.10.5 CR SANJIU Related Developments
• 11.1 Bayer
  • 11.1.1 Bayer Corporation Information
  • 11.1.2 Bayer Overview
  • 11.1.3 Bayer Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.1.4 Bayer Dermatology OTC Medications Product Description
  • 11.1.5 Bayer Related Developments
• 11.12 Lupin
  • 11.12.1 Lupin Corporation Information
  • 11.12.2 Lupin Overview
  • 11.12.3 Lupin Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.12.4 Lupin Product Description
  • 11.12.5 Lupin Related Developments
• 11.13 Bausch Health
  • 11.13.1 Bausch Health Corporation Information
  • 11.13.2 Bausch Health Overview
  • 11.13.3 Bausch Health Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.13.4 Bausch Health Product Description
  • 11.13.5 Bausch Health Related Developments
• 11.14 Cipla
  • 11.14.1 Cipla Corporation Information
  • 11.14.2 Cipla Overview
  • 11.14.3 Cipla Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.14.4 Cipla Product Description
  • 11.14.5 Cipla Related Developments
• 11.15 Qilu Pharmaceutical
  • 11.15.1 Qilu Pharmaceutical Corporation Information
  • 11.15.2 Qilu Pharmaceutical Overview
  • 11.15.3 Qilu Pharmaceutical Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.15.4 Qilu Pharmaceutical Product Description
  • 11.15.5 Qilu Pharmaceutical Related Developments
• 11.16 Almirall
  • 11.16.1 Almirall Corporation Information
  • 11.16.2 Almirall Overview
  • 11.16.3 Almirall Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.16.4 Almirall Product Description
  • 11.16.5 Almirall Related Developments
• 11.17 Lingrui
  • 11.17.1 Lingrui Corporation Information
  • 11.17.2 Lingrui Overview
  • 11.17.3 Lingrui Dermatology OTC Medications Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.17.4 Lingrui Product Description
  • 11.17.5 Lingrui Related Developments

12 Value Chain and Sales Channels Analysis

• 12.1 Dermatology OTC Medications Value Chain Analysis
• 12.2 Dermatology OTC Medications Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Dermatology OTC Medications Production Mode & Process
• 12.4 Dermatology OTC Medications Sales and Marketing
  • 12.4.1 Dermatology OTC Medications Sales Channels
  • 12.4.2 Dermatology OTC Medications Distributors
• 12.5 Dermatology OTC Medications Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

• 13.1 Dermatology OTC Medications Industry Trends
• 13.2 Dermatology OTC Medications Market Drivers
• 13.3 Dermatology OTC Medications Market Challenges
• 13.4 Dermatology OTC Medications Market Restraints

14 Key Findings in The Global Dermatology OTC Medications Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Author Details